semaglutide mcas A new American study explored how GLP‑1 medications (like or tirzepatide) might affect symptoms. Researchers didn't set out to study MCAS: they simply noticed that some patients who were prescribed GLP-1 Receptor Agonists: A Game-Changing

This work was supported by AFM-Telethon (grant 22982), AIRC (grant 23257), PRIN 2022 (grant 2022LZARA3), ASI (grant MARS-PRE), CARIPARO, Next Generation EU in the context of the National Recovery and Resilience Plan, Investment PE8 Project Age-It: Ageing Well in an Ageing Society to MS

For patients with HIV-associated lipodystrophy, specialist HIV clinics guided by BHIVA recommendations on metabolic complications may have more direct experience with tesamorelin

Conclusions : We investigated whether NAC could be used to reduce CKD progression to ESRD

Researchers are also exploring new compounds that could help preserve muscle mass during weight loss

P.ShenM.EisensteinR